Buhnerkempe MG - Search Results

1

Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort.

Buhnerkempe MG, Prakash V, Botchway A, Adekola B, Cohen JB, Rahman M, Weir MR, Ricardo AC, Flack JM. Buhnerkempe MG, et al. Hypertension. 2021 Jan;77(1):72-81. doi: 10.1161/HYPERTENSIONAHA.120.15064. Epub 2020 Nov 9. Hypertension. 2021. PMID: 33161774 Free PMC article.

2

Predicting the risk of apparent treatment-resistant hypertension: a longitudinal, cohort study in an urban hypertension referral clinic.

Buhnerkempe MG, Botchway A, Nolasco Morales CE, Prakash V, Hedquist L, Flack JM. Buhnerkempe MG, et al. J Am Soc Hypertens. 2018 Nov;12(11):809-817. doi: 10.1016/j.jash.2018.09.006. Epub 2018 Sep 20. J Am Soc Hypertens. 2018. PMID: 30392848

3

Prevalence of refractory hypertension in the United States from 1999 to 2014.

Buhnerkempe MG, Botchway A, Prakash V, Al-Akchar M, Nolasco Morales CE, Calhoun DA, Flack JM. Buhnerkempe MG, et al. J Hypertens. 2019 Sep;37(9):1797-1804. doi: 10.1097/HJH.0000000000002103. J Hypertens. 2019. PMID: 31058798

4

Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.

Botchway A, Buhnerkempe MG, Prakash V, Al-Akchar M, Adekola B, Flack JM. Botchway A, et al. Among authors: buhnerkempe mg. Am J Hypertens. 2020 May 21;33(6):528-533. doi: 10.1093/ajh/hpaa010. Am J Hypertens. 2020. PMID: 31930338

5

Impact of chronic kidney disease on in-hospital outcomes and readmission rate after edge-to-edge transcatheter mitral valve repair.

Sawalha K, Al-Akchar M, Ibrahim A, Buhnerkempe M, Koester C, Salih M, Bhattarai M, Tandan N, Bhatt DL, Hafiz AM. Sawalha K, et al. Catheter Cardiovasc Interv. 2021 Mar;97(4):E569-E579. doi: 10.1002/ccd.29188. Epub 2020 Aug 15. Catheter Cardiovasc Interv. 2021. PMID: 32969155

6

Race and Antihypertensive Drug Therapy: Edging Closer to a New Paradigm.

Flack JM, Buhnerkempe MG. Flack JM, et al. Among authors: buhnerkempe mg. Hypertension. 2022 Feb;79(2):349-351. doi: 10.1161/HYPERTENSIONAHA.121.18545. Epub 2022 Jan 12. Hypertension. 2022. PMID: 35020461 Free article. No abstract available.

7

Resistant Hypertension: Disease Burden and Emerging Treatment Options.

Flack JM, Buhnerkempe MG, Moore KT. Flack JM, et al. Among authors: buhnerkempe mg. Curr Hypertens Rep. 2024 May;26(5):183-199. doi: 10.1007/s11906-023-01282-0. Epub 2024 Feb 16. Curr Hypertens Rep. 2024. PMID: 38363454 Free PMC article. Review.

8

Sacubitril/Valsartan as an Effective Hypertension Treatment Option in Those With Chronic Type B Aortic Dissection.

Buhnerkempe MG, Bitner S, Flack JM. Buhnerkempe MG, et al. Am J Hypertens. 2024 Jul 15;37(8):543-545. doi: 10.1093/ajh/hpae054. Am J Hypertens. 2024. PMID: 38708518 No abstract available.

9

Fixed-rate insulin for adult diabetic ketoacidosis is associated with more frequent hypoglycaemia than rate-reduction method: a retrospective cohort study.

Lorenson JL, Cusumano MC, Stewart AM, Buhnerkempe MG, Sanghavi D. Lorenson JL, et al. Among authors: buhnerkempe mg. Int J Pharm Pract. 2019 Aug;27(4):380-385. doi: 10.1111/ijpp.12525. Epub 2019 Mar 8. Int J Pharm Pract. 2019. PMID: 30847977

10

Endovascular Thrombolysis or Thrombectomy for Cerebral Venous Thrombosis: Study of Nationwide Inpatient Sample 2004-2014.

Siddiqui FM, Weber MW, Dandapat S, Scaife S, Buhnerkempe M, Ortega-Gutierrez S, Aksan N, Elias A, Coutinho JM. Siddiqui FM, et al. J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1440-1447. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.025. Epub 2019 Apr 2. J Stroke Cerebrovasc Dis. 2019. PMID: 30952531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters